why choose us

Clinical Trials Search

Showing 7,290 of 132,085 result(s)
Mirdametinib in Histiocytic Disorders

Status: Completed

Condition: Langerhans Cell Histiocytosis (LCH)

Interventions: Mirdametinib is administered at a dose of 2 mg;m2, twice a day (BID) with a maximum dose of 4 mg BID on a continuous daily schedule.
Consecu

Date: 2023-10-11

5-Day Preoperative Radiation for Soft Tissue Sarcoma

Status: Completed

Condition: Soft Tissue Sarcoma

Interventions: Radiation will be delivered by external beam techniques to the tumor and areas of possible microscopic disease at a dose of 30 Gy divided into 5 equal

Date: 2023-10-11

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Status: COMPLETED

Condition: Cancer

Interventions: Clinical data for all enrolled patients will be abstracted from the electronic medical record.
This will include but will not be limited to patie

Date: 2023-10-11

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Status: COMPLETED

Condition: Alzheimer's Disease (AD)

Interventions: Drug: SHR-1707 SHR-1707 will be administered through IV infusion.
Drug: Placebo Placebo will be administered through IV infusion

Date: 2023-10-11

Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand;Wrist Surgery

Status: COMPLETED

Condition: Wrist Disease

Interventions: administration of 0.5ml;kg of 0,2% ropivacaine + 0.01ml;kg 0.9% sodium chloride for the supraclavicular brachial plexus block

Date: 2023-10-11

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Status: COMPLETED

Condition: Gram-Negative Bacterial Infections

Interventions: Administered via intravenous (IV) infusion

Date: 2023-10-11

Pediatric Readiness Intervention in Manitoba

Status: COMPLETED

Condition: Pediatric Readiness

Interventions: Pediatric resource toolkits availability via TREKK for Kids Ongoing interactions, and intensive training and education sessions

Date: 2023-10-11

Clinical Performance Evaluation of T-TAS®01 HD Chip

Status: COMPLETED

Condition: Thrombocytopenia

Interventions: Disposable flow chamber microchip containing thrombogenic path to facilitate thrombus formation and occlusion

Date: 2023-10-11

Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial

Status: COMPLETED

Condition: Type 2 Diabetes Mellitus

Interventions: Henagliflozin will be initiated and maintained at 5mg;day every morning.
If necessary, the dose can be increased to 10mg once daily.
Al

Date: 2023-10-10

Chlorhexidine Gluconate Bathing Education Video Among Hospitalized Patients

Status: COMPLETED

Condition: Infections

Interventions: Short CHG skin treatment video that reviews the rationale;importance of CHG bathing, and the appropriate process for bathing

Date: 2023-10-10